Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts

Breast tumors comprise an infrequent tumor cell population, termed breast tumor initiating cells (BTIC), which sustain tumor growth, seed metastases and resist cytotoxic therapies. Hence therapies are needed to target BTIC to provide more durable breast cancer remissions than are currently achieved....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Gwynne, William D, Hallett, Robin M, Girgis-Gabardo, Adele, Bojovic, Bojana, Dvorkin-Gheva, Anna, Aarts, Craig, Dias, Kay, Bane, Anita, Hassell, John A
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458271/
https://ncbi.nlm.nih.gov/pubmed/28404880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16646
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares